Related Experiment Video
Updated: Jul 14, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Temporary circulatory support with surgically implanted microaxial pumps in postcardiotomy cardiogenic shock
Wiebke Sommer1, Rawa Arif1, Jamila Kremer1
1Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany.
Insights
Simultaneous Impella 5.0/5.5 pump implantation during coronary artery bypass grafting (CABG) surgery improves survival in patients with ischemic cardiomyopathy compared to delayed implantation. Early hemodynamic support is key for better outcomes.
Area of Science:
- Cardiovascular Surgery
- Mechanical Circulatory Support
- Cardiac Surgery Outcomes
Background:
- Post-cardiotomy cardiogenic shock is a risk for patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (CABG).
- Microaxial pumps like Impella 5.0/5.5 offer full hemodynamic support and left ventricular unloading.
- These devices can be crucial for managing severe left ventricular failure post-CABG.
Purpose of the Study:
- To evaluate the impact of the timing of Impella 5.0/5.5 implantation on patient survival.
- To compare outcomes between simultaneous (during CABG) and delayed Impella implantation.
- To assess the efficacy of microaxial pumps in patients with postcardiotomy cardiogenic shock.
Main Methods:
- Retrospective analysis of 42 patients receiving Impella 5.0/5.5 support post-CABG (Sept 2017 - Oct 2022).
- Patients were divided into two groups: simultaneous implantation during CABG and delayed implantation.
- Preoperative, perioperative, and postoperative data were collected and analyzed.
Main Results:
- Simultaneous implantation (n=27) showed significantly better 30-day survival (75.6% vs 47.6%, P=0.04) and 1-year survival (69.4% vs 29.8%, P=0.03) compared to delayed implantation (n=15).
- Preoperative left ventricular ejection fraction was similarly low in both groups, indicating comparable baseline severity.
- Delayed Impella implantation occurred a median of 1 day after CABG surgery.
Conclusions:
- Combined hemodynamic support and left ventricular unloading with Impella pumps can improve survival in post-CABG left ventricular failure.
- Early implantation of Impella during the initial CABG surgery demonstrates a trend towards more favorable survival outcomes.
- This suggests that timely initiation of mechanical circulatory support is critical for managing severe cardiac dysfunction post-surgery.
Objectives:
Patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (CABG) surgery may develop postcardiotomy cardiogenic shock. In these cases, implantation of an Impella 5.0 or 5.5 microaxial pump offers full hemodynamic support while simultaneously unloading of the left ventricle.
Methods:
Preoperative, perioperative, and postoperative data of all patients receiving postoperative support with an Impella 5.0 or 5.5 after CABG surgery between September 2017 and October 2022 were retrospectively collected. Cohort built-up was performed according to the timing of Impella implantation, either simultaneous during CABG surgery or delayed.
Results:
A total of n = 42 patients received postoperative Impella support, of whom 27 patients underwent simultaneous Impella implantation during CABG surgery and 15 patients underwent delayed Impella therapy. Preoperative left ventricular ejection fraction was similarly low in both groups (26.7 ± 0.7% vs 24.8 ± 11.3%; P = .32). In the delayed cohort, Impella implantation was performed after a median of 1 (1; 2) days after CABG surgery. Survival after 30 days (75.6% vs 47.6%, P = .04) and 1 year (69.4% vs 29.8%, P = .03) was better in the cohort receiving simultaneous Impella implantation.
Conclusions:
The combined advantages of hemodynamic support and LV unloading with microaxial pumps may lead to a favorable survival in patients with left ventricular failure following CABG surgery. Early implantation during the initial surgery shows a trend toward a more favorable survival as compared with patients receiving delayed support.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy V: Interprofessional Care

